Back
Enlivex Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
17
ENLV
Enlivex Therapeutics
Last Price:
1.06
Seasonality Move:
14.56%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight buying pressure.
Enlivex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Sell |
| 20-day SMA: | 1.33 | Sell |
| 50-day SMA: | 1.43 | Sell |
| 200-day SMA: | 1.9 | Sell |
| 8-day EMA: | 1.18 | Sell |
| 20-day EMA: | 1.29 | Sell |
| 50-day EMA: | 1.37 | Sell |
| 200-day EMA: | 1.73 | Sell |
Enlivex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 23.24 | Sell |
| Chaikin Money Flow: | 43470 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.53) | Sell |
| Bollinger Bands (100): | (1.25 - 1.51) | Sell |
Enlivex Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enlivex Therapeutics Stock
Is Enlivex Therapeutics Stock a Buy?
- Enlivex Therapeutics share price is 1.07 while ENLV 8-day simple moving average is 1.18, which is a Sell signal.
- The stock price of ENLV is 1.07 while Enlivex Therapeutics 20-day SMA is 1.33, which makes it a Sell.
- Enlivex Therapeutics 50-day simple moving average is 1.43 while ENLV share price is 1.07, making it a Sell technically.
- ENLV stock price is 1.07 and Enlivex Therapeutics 200-day simple moving average is 1.90, creating a Sell signal.
ENLV Technical Analysis vs Fundamental Analysis
Sell
17
Enlivex Therapeutics (ENLV)
is a Sell
Is Enlivex Therapeutics a Buy or a Sell?
-
Enlivex Therapeutics stock is rated a Sell
The current Enlivex Therapeutics [ENLV] share price is $1.07. The Score for ENLV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Enlivex Therapeutics Stock Info
Market Cap:
22.9M
Price in USD:
1.07
Share Volume:
130.41K
Enlivex Therapeutics 52-Week Range
52-Week High:
4.59
52-Week Low:
1.01
Sell
17
Enlivex Therapeutics (ENLV)
is a Sell
Enlivex Therapeutics Share Price Forecast
-
What is the Enlivex Therapeutics stock price today?
The Enlivex Therapeutics stock price is 1.07 USD today. -
Will ENLV stock go up or go down?
Enlivex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Enlivex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enlivex Therapeutics is overvalued.
Is Enlivex Therapeutics Stock a Buy?
- Enlivex Therapeutics share price is 1.07 while ENLV 8-day exponential moving average is 1.18, which is a Sell signal.
- The stock price of ENLV is 1.07 while Enlivex Therapeutics 20-day EMA is 1.29, which makes it a Sell.
- Enlivex Therapeutics 50-day exponential moving average is 1.37 while ENLV share price is 1.07, making it a Sell technically.
- ENLV stock price is 1.07 and Enlivex Therapeutics 200-day simple moving average is 1.73, creating a Sell signal.
Fundamental Analysis of Enlivex Therapeutics
Is Enlivex Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.10 per share.
Technical Analysis of Enlivex Therapeutics
Should I short Enlivex Therapeutics stock?
- ENLV Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Enlivex Therapeutics is a Sell
- Enlivex Therapeutics Relative Strength Index (RSI) is 23.24, which suggest Enlivex Therapeutics is oversold
- The Bollinger Bands (25) for Enlivex Therapeutics is (1.21 - 1.53), which suggest Enlivex Therapeutics is a Sell
- The Bollinger Bands (100) for Enlivex Therapeutics is (1.25 - 1.51), which suggest Enlivex Therapeutics is a Sell
* Enlivex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.